Key result
Incorporating frailty screening tools into palliative care consultations for patients with advanced heart failure was feasible, achieving an overall completion rate of 86%.
Why the study?
The feasibility of routinely incorporating frailty screening tools into daily clinical practice among hospitalised advanced HF patients has not been rigorously tested.
Is it feasible to routinely incorporate frailty screening into daily clinical practice among hospitalized advanced HF patients?
Observational (n=212)
No
Is it feasible to routinely incorporate frailty screening into daily clinical practice among hospitalized advanced HF patients?
Questionnaire-based frailty screening tools like CFS and mSOF are highly feasible to implement in hospitalized patients with advanced heart failure.
Answers are grounded in this paper and cite their sources.
May support incorporating brief frailty tools into advanced HF palliative assessments; leaves open effects on care decisions or outcomes.
BACKGROUND: Frailty is common among patients with advanced heart failure (HF), and screening for frailty to guide care is recommended. Although multiple tools are available to screen for frailty, the feasibility of routinely incorporating frailty screening into daily clinical practice among hospitalised advanced HF patients has not been rigorously tested. METHODS: This was a prospective, single-centre, quality improvement study. Two brief frailty screening tools were incorporated into palliative care consultations for all patients ≥50 years from August 2021 to October 2022. In the first phase, the Clinical Frailty Scale (CFS) was implemented, followed by the Study of Osteoporotic Fracture (SOF) tool or a modified SOF (mSOF) version in the second phase. The primary outcome was feasibility (%) of performing frailty screenings for this high-risk population. RESULTS: A total of 212 patients (mean age 69±10 years, 69% male, 79% white, 30% with ischaemic HF) were referred for palliative care consultation during the study period. Overall, frailty screens were completed in 86% (n=183) of patients. CFS and mSOF reached >80% of adoption, while SOF adoption was 54%. Altogether, 52% of the population screened frail by use of CFS and 52% also by mSOF. All clinicians (n=6) participating in the study reported that frailty screening tools were useful and acceptable, and 83% reported plans for continued utilisation in future clinical practice. CONCLUSIONS: Frailty screening with CFS or mSOF tools was feasible in hospitalised patients with advanced HF. Tools that require physical assessment were more challenging to implement. These data support the feasibility of incorporating questionnaire-based frailty screening in a busy hospital setting.
No takes yet. Share an insight, caveat, or question.
Lehto et al. (2023) conducted an observational in Advanced heart failure (n=212). Frailty screening tools (CFS, SOF, mSOF) was evaluated on Feasibility (%) of performing frailty screenings. Incorporating frailty screening tools into palliative care consultations for patients with advanced heart failure was feasible, achieving an overall completion rate of 86%.
Synapse has enriched 10 related papers. Consider them for comparative context: